Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants
Bin Tu, Huiyuan Wang, Xinran An, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 3187-3194
Open Access | Times Cited: 17

Showing 17 citing articles:

A review on multifaceted biomedical applications of heparin nanocomposites: Progress and prospects
Mukesh Kumar Meher, Goutami Naidu, Amit Mishra, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129379-129379
Closed Access | Times Cited: 11
Defining diverse Spike-Receptor interactions involved in SARS-CoV-2 entry: Mechanisms and Therapeutic Opportunities
Michael Anderson, Julian Lopez, Maya Wyr, et al.
Virology (2025), pp. 110507-110507
Open Access | Times Cited: 1
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery
Thiago Medeiros Zacaron, Mariana Leite Simões e Silva, Mirsiane Pascoal Costa, et al.
Polymers (2023) Vol. 15, Iss. 18, pp. 3849-3849
Open Access | Times Cited: 22
Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections
Ching-Yee Loo, Wing‐Hin Lee, Qi Zhou
Pharmaceutical Research (2023) Vol. 40, Iss. 5, pp. 1015-1036
Open Access | Times Cited: 15
Antiviral polysaccharide and antiviral peptide delivering nanomaterials for prevention and treatment of SARS-CoV-2 caused COVID-19 and other viral diseases
Shahin Homaeigohar, Xuan Liu, Mady Elbahri
Journal of Controlled Release (2023) Vol. 358, pp. 476-497
Open Access | Times Cited: 14
A Potential 3‐in‐1 Combined AntiSARS‐CoV‐2 Therapy Using Pulmonary MIL‐100(Fe) Formulation
Beatrice Fodor, Inés Álvarez‐Miguel, Catalina Biglione, et al.
Advanced Healthcare Materials (2025)
Closed Access
Phytochemical-based nanosystems: recent advances and emerging application in antiviral photodynamic therapy
Yan Shan Loo, Nur Aininie Yusoh, Wai Feng Lim, et al.
Nanomedicine (2025), pp. 1-16
Closed Access
Heparan Sulfate and Sialic Acid in Viral Attachment: Two Sides of the Same Coin?
Iván Ramos-Martínez, Edgar Ramos-Martínez, René Segura‐Velázquez, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9842-9842
Open Access | Times Cited: 16
Chitosan-Based Nanoformulations: Preclinical Investigations, Theranostic Advancements, and Clinical Trial Prospects for Targeting Diverse Pathologies
Seema Yadav, Abhishek Singh, Narahari N. Palei, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 8
Closed Access | Times Cited: 3
Inhaled heparin: Past, present, and future
Zhewei Liu, Yuqing Ye, Ying Ma, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104065-104065
Open Access | Times Cited: 2
Localized delivery of nanomedicine and antibodies for combating COVID-19
Bin Tu, Yanrong Gao, Xinran An, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 1828-1846
Open Access | Times Cited: 9
Pathogen‐binding nanoparticles to inhibit host cell infection by heparan sulfate and sialic acid dependent viruses and protozoan parasites
Adrian Najer
Smart Medicine (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1
Heparin-Conjugated ACE2-Bearing Extracellular Vesicles As Engineered Dual-Decoy for Combating the SARS-CoV-2 Omicron Variant via Pulmonary Delivery
Bin Tu, Zhenzhen Pan, Huiyuan Wang, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 4, pp. 1247-1255
Closed Access | Times Cited: 1
Cellular vesicles-based “all-in-one” vaccine platform triggers mucosal immunity against respiratory viruses
Yanrong Gao, Jie Zhu, Jimao Zhai, et al.
Nano Today (2024) Vol. 59, pp. 102473-102473
Open Access | Times Cited: 1
Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19
Shuai Yang, Ying Tong, Lu Chen, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Mycolactone: A Broad Spectrum Multitarget Antiviral Active in the Picomolar Range for COVID-19 Prevention and Cure
Seth O. Asiedu, Yash Gupta, Vlad Nicolaescu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7151-7151
Open Access
Page 1

Scroll to top